BUONFIGLIOLI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 2.868
AS - Asia 2.791
EU - Europa 1.557
AF - Africa 160
SA - Sud America 92
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.473
Nazione #
US - Stati Uniti d'America 2.839
VN - Vietnam 1.173
SG - Singapore 706
CN - Cina 484
GB - Regno Unito 431
SE - Svezia 227
DE - Germania 197
IT - Italia 164
HK - Hong Kong 139
FR - Francia 108
IN - India 103
RU - Federazione Russa 96
IE - Irlanda 75
CI - Costa d'Avorio 61
BR - Brasile 60
NL - Olanda 59
ZA - Sudafrica 46
UA - Ucraina 44
EE - Estonia 39
KR - Corea 39
JP - Giappone 35
TG - Togo 30
BG - Bulgaria 24
FI - Finlandia 21
PH - Filippine 21
CA - Canada 20
CH - Svizzera 18
JO - Giordania 15
BD - Bangladesh 13
PL - Polonia 13
EC - Ecuador 10
TH - Thailandia 10
BE - Belgio 9
GR - Grecia 9
TR - Turchia 9
AR - Argentina 8
ES - Italia 8
TW - Taiwan 8
IQ - Iraq 7
MX - Messico 7
NG - Nigeria 7
AT - Austria 6
PK - Pakistan 6
SA - Arabia Saudita 6
IR - Iran 5
SC - Seychelles 5
AU - Australia 4
CL - Cile 3
MA - Marocco 3
PE - Perù 3
CO - Colombia 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ID - Indonesia 2
LB - Libano 2
MK - Macedonia 2
MY - Malesia 2
PY - Paraguay 2
SI - Slovenia 2
UY - Uruguay 2
UZ - Uzbekistan 2
BH - Bahrain 1
BO - Bolivia 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GN - Guinea 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LT - Lituania 1
MT - Malta 1
NP - Nepal 1
RS - Serbia 1
SN - Senegal 1
TL - Timor Orientale 1
TN - Tunisia 1
VE - Venezuela 1
VG - Isole Vergini Britanniche 1
Totale 7.473
Città #
Singapore 529
Southend 379
Ashburn 341
Fairfield 330
Ho Chi Minh City 279
Hanoi 260
Chandler 232
Woodbridge 146
Hong Kong 130
Houston 126
Seattle 121
Wilmington 116
San Jose 113
Santa Clara 104
Ann Arbor 101
Dong Ket 96
Cambridge 83
Boardman 80
Princeton 78
Dublin 75
Beijing 64
Abidjan 61
Dallas 48
Da Nang 47
Hefei 44
Los Angeles 41
Bologna 40
Westminster 40
Haiphong 35
New York 34
Lauterbourg 33
Tokyo 33
Nanjing 32
Lomé 30
Medford 27
Bremen 25
Saint Petersburg 25
Sofia 24
Dearborn 23
Milan 23
Padova 23
Seoul 23
Buffalo 22
Florence 21
Ha Long 21
Council Bluffs 20
Biên Hòa 19
Hải Dương 19
Thái Nguyên 19
Berlin 17
Munich 17
Can Tho 16
Falls Church 16
Quận Bình Thạnh 16
Amman 15
Changsha 14
Frankfurt am Main 14
San Diego 14
Helsinki 13
Bắc Ninh 12
Guangzhou 12
Jacksonville 12
Jinan 12
Redondo Beach 12
Shenyang 12
Bern 11
Pune 11
Xi'an 11
Bắc Giang 10
Brussels 9
Des Moines 9
Hebei 9
London 9
Ninh Bình 9
Shanghai 9
São Paulo 9
Tianjin 9
Toronto 9
Turin 9
Zhengzhou 9
Jiaxing 8
Quận Phú Nhuận 8
Turku 8
Falkenstein 7
Johannesburg 7
Nanchang 7
Orem 7
Vinh 7
Vũng Tàu 7
Abeokuta 6
Bangkok 6
Chicago 6
Guayaquil 6
Montreal 6
Quảng Ngãi 6
Quận Ba 6
Tây Ninh 6
Uyen Hung 6
Warsaw 6
Yubileyny 6
Totale 5.133
Nome #
G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence 608
Outcomes and survival after TIPS positioning: a single center experience 403
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 235
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 213
Adverse effects of proton pump inhibitors. 213
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 213
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 210
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 206
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 203
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 201
Alisporivir for the treatment of chronic HCV 196
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 193
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis 189
Severe immune thrombocytopenia after peg-interferonalpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literature 185
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 180
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 177
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 176
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 171
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 170
Four-year follow-up of psychiatric and psychosomatic profile in patients with Inflammatory Bowel Disease (IBD) 167
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 162
Indocyanine Green 15-min Retention test (ICG-r15) as a predictor of clinical decompensation in patients with compensated liver cirrhosis. 157
Indocyanine green clearance (ICG) as a predictor of 2-years clinical decompensation and mortality in patients with compensated liver cirrhosis 156
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 156
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 154
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis 154
Indocyanine Green Clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis 154
Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum 151
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 149
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 149
Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy. 148
UDCA UP-REGULATES HUMAN PLACENTAL BCRP EXPRESSION: PRELIMINARY RESULTS 141
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 137
UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY 133
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 129
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals 129
RIBAVIRIN PRIMING ENHANCES EFFICACY OF CHRONIC HEPATITIS C RE-TREATMENT IN PATIENTS WHO HAD NOT RESPONDED TO PREVIOUS COMBINATION THERAPY 127
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 118
Outcomes and survival after TIPS positioning: a single center experience 116
null 107
null 96
null 65
Lamivudine treatment for severe acute HBV hepatitis. 65
THE GASTROPACK SYSTEM, A NOVEL METHOD TO ACCESS TO GASTROENTEROLOGICAL CARE: RESULTS OF THE UPPER GASTROINTESTINAL SYMPTOM POPULATION 30
Totale 7.592
Categoria #
all - tutte 18.086
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.086


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021189 0 0 0 0 0 0 0 0 0 32 25 132
2021/2022886 94 24 36 54 69 43 12 47 24 39 303 141
2022/2023859 84 119 50 128 56 83 21 42 152 18 64 42
2023/2024265 9 46 8 22 14 89 10 16 25 5 11 10
2024/2025936 52 141 96 50 133 35 41 25 26 71 45 221
2025/20262.751 816 161 184 136 265 129 260 78 554 168 0 0
Totale 7.592